Abstract:Background: Acute kidney injury (AKI) remains a major global public health concern due to its high morbidity and mortality. The progression from AKI to chronic kidney disease (CKD) makes it a scientific problem to be solved. However, it is with lack of effective treatments. Summary: Both innate and adaptive immune systems participate in the inflammatory process during AKI, and excessive or dysregulated immune responses play a pathogenic role in renal fibrosis, which is an important hallmark of CKD. Studies on the pathogenesis of AKI and CKD have clarified that renal injury induces the production of various chemokines by renal parenchyma cells or resident immune cells, which recruits multiple-subtype lymphocytes in circulation. Some infiltrated lymphocytes exacerbate injury by proinflammatory cytokine production, cytotoxicity, and interaction with renal resident cells, which constructs the inflammatory environment and induces further injury, even death of renal parenchyma cells. Others promote tissue repair by producing protective cytokines. In this review, we outline the diversity of these lymphocytes and their mechanisms to regulate the whole pathogenic stages of AKI and CKD; discuss the chronological responses and the plasticity of lymphocytes related to AKI and CKD progression; and introduce the potential therapies targeting lymphocytes of AKI and CKD, including the interventions of chemokines, cytokines, and lymphocyte frequency regulation in vivo , adaptive transfer of ex-expanded lymphocytes, and the treatments of gut microbiota or metabolite regulations based on gut-kidney axis. Key Message: In the process of AKI and CKD, T helper (Th) cells, innate, and innate-like lymphocytes exert mainly pathogenic roles, while double-negative T (DNT) cells and regulatory T cells (Tregs) are confirmed to be protective. Understanding the mechanisms by which lymphocytes mediate renal injury and renal fibrosis is necessary to promote the development of specific therapeutic strategies to protect from AKI and prevent the progression of CKD.

The renal immune compartmentalization and the tubulointerstitial injury

Separated Parabiont Reveals the Fate and Lifespan of Peripheral-Derived Immune Cells in Normal and Ischaemia-Induced Injured Kidneys

The pathological role of damaged organelles in renal tubular epithelial cells in the progression of acute kidney injury

Interaction Between Intrinsic Renal Cells and Immune Cells in the Progression of Acute Kidney Injury

Dendritic Cells: Versatile Players in Renal Transplantation.

How Tubular Epithelial Cell Injury Contributes to Renal Fibrosis

Renal tubule injury: a driving force toward chronic kidney disease

Compartmentalization of immune system and regulatory effects of epithelial cells in local microenvironment

Kidney and innate immunity

Pathogenesis and treatment progress in chronic kidney disease after acute kidney injury

Lymphocytes: Versatile Participants in Acute Kidney Injury and Progression to Chronic Kidney Disease

Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms

Kidney-Immune System Crosstalk in AKI

Renal tubular epithelial cells: the neglected mediator of tubulointerstitial fibrosis after injury

Crosstalk between proximal tubular epithelial cells and other interstitial cells in tubulointerstitial fibrosis after renal injury

Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy

Immune Mechanisms and Novel Pharmacological Therapies of Acute Kidney Injury

The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease

Mechanisms of injury and repair of acute kidney injury

Integration of spatial and single-cell transcriptomics localizes epithelial cell–immune cross-talk in kidney injury